Barclays PLC lifted its stake in Cibus, Inc. (NASDAQ:CBUS – Free Report) by 287.2% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 20,269 shares of the company’s stock after purchasing an additional 15,034 shares during the quarter. Barclays PLC owned 0.08% of Cibus worth $66,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently bought and sold shares of the company. FMR LLC raised its holdings in shares of Cibus by 16.9% during the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock valued at $12,757,000 after acquiring an additional 566,328 shares during the period. Armistice Capital LLC acquired a new stake in Cibus during the 2nd quarter valued at $5,083,000. State Street Corp lifted its holdings in shares of Cibus by 43.6% in the third quarter. State Street Corp now owns 307,262 shares of the company’s stock valued at $1,002,000 after purchasing an additional 93,236 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Cibus in the second quarter worth $529,000. Finally, Swan Global Investments LLC purchased a new position in shares of Cibus during the third quarter valued at $115,000. Hedge funds and other institutional investors own 33.81% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. HC Wainwright restated a “buy” rating and set a $25.00 price objective on shares of Cibus in a research report on Monday, November 11th. Alliance Global Partners decreased their price target on shares of Cibus from $25.00 to $23.50 and set a “buy” rating for the company in a report on Tuesday, September 24th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $20.00 price objective on shares of Cibus in a research note on Tuesday, October 22nd.
Cibus Price Performance
Shares of CBUS stock opened at $2.58 on Friday. Cibus, Inc. has a fifty-two week low of $2.35 and a fifty-two week high of $23.18. The stock’s 50-day moving average is $3.87 and its two-hundred day moving average is $5.56. The firm has a market cap of $68.26 million, a P/E ratio of -0.11 and a beta of 1.85.
Cibus Profile
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Articles
- Five stocks we like better than Cibus
- The Risks of Owning Bonds
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Dividend Payout Ratio Calculator
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Stock Dividend Cuts Happen Are You Ready?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.